315 related articles for article (PubMed ID: 23347903)
41. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.
Sainati L; Matutes E; Mulligan S; de Oliveira MP; Rani S; Lampert IA; Catovsky D
Blood; 1990 Jul; 76(1):157-62. PubMed ID: 2364167
[TBL] [Abstract][Full Text] [Related]
42. Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma.
Soliman DS; Ibrahim F; Fernyhough LJ; Murad F; Akiki S
J Hematol; 2022 Feb; 11(1):21-28. PubMed ID: 35356636
[TBL] [Abstract][Full Text] [Related]
43. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
Sokol L; Agosti SJ
Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
[TBL] [Abstract][Full Text] [Related]
45. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract][Full Text] [Related]
46. Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
Wang Y; Wang T; Yu Y; Wang Q; Yan Y; Li R; Sun Q; Xiong W; Lyu R; Yu Z; Liu W; Sui W; Huang W; Wang H; Li C; Wang J; Zou D; An G; Wang J; Qiu L; Yi S
Ann Hematol; 2022 Jun; 101(6):1201-1210. PubMed ID: 35437610
[TBL] [Abstract][Full Text] [Related]
47. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY
Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of hairy cell leukaemia by fine needle aspiration cytology of lymph node.
Suneel R; Rajasekaran S; Kaur H; Mallik N; Garg D; Jain A; Dey P
Diagn Cytopathol; 2021 Apr; 49(4):E167-E171. PubMed ID: 33002340
[TBL] [Abstract][Full Text] [Related]
49. [Hairy lymphoproliferations: a case report and review of the literature].
Julien M; Latger-Cannard V; Salignac S; Aubert C; Gérard D; Broseus J; Lesesve JF
Ann Biol Clin (Paris); 2022 Jun; 80(3):252-258. PubMed ID: 35796473
[TBL] [Abstract][Full Text] [Related]
50. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
51. Lymphomatous variant of hairy cell leukaemia: a distinctive presentation mimicking low-grade B-cell lymphoma.
Liu H; Wang W; Tang G; Yin CC; Muzzafar T; Medeiros LJ; Hu S
Histopathology; 2015 Nov; 67(5):740-5. PubMed ID: 25809821
[TBL] [Abstract][Full Text] [Related]
52. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract][Full Text] [Related]
53. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
54. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.
Abdel-Ghafar AA; El Din El Telbany MA; Mahmoud HM; El-Sakhawy YN
Hematol Rep; 2012 Jan; 4(1):e3. PubMed ID: 22567217
[TBL] [Abstract][Full Text] [Related]
55. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
56. Hairy cell leukemia-variant--a case report.
Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
[TBL] [Abstract][Full Text] [Related]
57. [Clinicopathologic study of 15 splenectomy specimens of patients with hairy cell leukemia].
Li ZQ; Chen HS; Liu EB; Sun Q; Fang LH; Sun FJ; Zhang PH; Yang QY; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):769-73. PubMed ID: 20079018
[TBL] [Abstract][Full Text] [Related]
58. Hairy cell leukemia: early immunophenotypical detection and quantitative analysis by flow cytometry.
Babusíková O; Tomová A
Neoplasma; 2003; 50(5):350-6. PubMed ID: 14628088
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity.
Rozenvald IB; Richardson MD; Brock L; Maiese RL
Arch Pathol Lab Med; 2017 Jun; 141(6):837-840. PubMed ID: 28418282
[TBL] [Abstract][Full Text] [Related]
60. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
